US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.75

+0.38001.11%

Post-market: 34.750.00000.00%16:15 EDT

Volume:100.22K

Turnover:3.46M

Market Cap:107.73M

PE:- -

High:34.80

Open:34.53

Low:34.07

Close:34.37

52wk High:36.84

52wk Low:25.00

Shares:3.10M

Float Shares:3.10M

Volume Ratio:1.32

T/O Rate:3.23%

Dividend:0.39

Dividend Rate:1.13%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology

CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B

Teva Wins US FDA Approval for Xgeva Biosimilar Degevma

Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone

Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)

Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study

Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%

Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook

US Drugmakers Turn to China for Licensing Deals

Mabwell's Subsidiary Lianwei Chuangyuan to Bring In Investors, Aiming to Boost Innovative Drug Business

Changchun High-Tech's GenSci136 Injection Receives Approval for Domestic Clinical Trial Application

Xilio Therapeutics Names Yariv Houvras Chief Medical Officer

Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals

Sun-Novo Pharmaceutical's STC008 Injection Meets Expected Goals in Phase I Trial for Cancer Cachexia in Advanced Solid Tumors

Betta Pharmaceuticals (300558.SZ): BPI-572270 Capsules Approved for Clinical Trials in Australia

Wuhan Hiteck Biological Pharma Secures Clinical Trial Approval for Epranemide Injection

Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection

Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors

Sichuan Biokin Pharmaceutical Receives Clinical Trial Approval for Injectable BL-M12D1 (ADC)

Regeneron (REGN) Receives a Hold from Bernstein

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigeractivity.com/stock/IBBQ/news?page=6"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"IBBQ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","market":"US","secType":"STK","nameCN":"Invesco Nasdaq Biotechnology ETF","latestPrice":34.75,"timestamp":1791230400000,"preClose":34.37,"halted":0,"volume":100219,"hourTrading":{"tag":"盘后","latestPrice":34.75,"preClose":34.75,"latestTime":"16:15 EDT","volume":155,"amount":5386.25,"timestamp":1791231300300,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.011056153622345143,"floatShares":3100001,"shares":3100001,"eps":0,"marketStatus":"Post-Mkt","change":0.38,"latestTime":"10-05 18:02:59 EDT","open":34.53,"high":34.8,"low":34.07,"amount":3459472,"amplitude":0.021239,"askPrice":35.09,"askSize":8500,"bidPrice":34.33,"bidSize":8700,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1791244800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":34.37,"sharesOutstanding":2520001,"nav":34.4248,"aum":106440372.14,"dividendRate":0.011275,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":34.37,"preClose":34.37,"latestTime":"07:35 EDT","volume":1,"amount":34.37,"timestamp":1791200149459,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":34.75,"preClose":34.75,"latestTime":"16:15 EDT","volume":155,"amount":5386.25,"timestamp":1791231300300,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.31821,"impliedVol":0.073,"impliedVolPercentile":0.1833},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBBQ\",,,,,undefined,":{"symbol":"IBBQ","floatShares":3100001,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.31821,"shares":3100001,"dividePrice":0.3918,"high":34.8,"amplitude":0.021239,"preClose":34.37,"low":34.07,"week52Low":25,"pbRate":"--","week52High":36.84,"institutionHeld":0,"latestPrice":34.75,"committee":0.011628,"eps":0,"divideRate":0.011275,"volume":100219,"delay":0,"ttmEps":0,"open":34.53,"prevYearClose":28.3962,"prevWeekClose":34.37,"prevMonthClose":35.14,"prevQuarterClose":35.14,"fiveDayClose":35.28,"twentyDayClose":36.05,"sixtyDayClose":33.09},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBBQ\",params:#limit:5,,,undefined,":[{"date":"2026-09-21","symbol":"IBBQ","amount":0.23037,"announcedDate":"2026-09-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-21","defaultRemindTime":1789997400000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-25","payableDate":"2026-09-21","currency":"USD","dateTimestamp":1789963200000,"payDate":"2026-09-25"},{"date":"2026-06-22","symbol":"IBBQ","amount":0.03422,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-26","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-26"},{"date":"2026-03-23","symbol":"IBBQ","amount":0.03609,"announcedDate":"2026-03-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-23","defaultRemindTime":1774272600000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-27","payableDate":"2026-03-23","currency":"USD","dateTimestamp":1774238400000,"payDate":"2026-03-27"},{"date":"2025-12-22","symbol":"IBBQ","amount":0.0906,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2025-09-22","symbol":"IBBQ","amount":0.09576,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"Invesco Nasdaq Biotechnology ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-26","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBBQ\",market:\"US\",,,undefined,":[{"executeDate":"2021-09-20","recordDate":"2021-09-21","paymentDate":"2021-09-30","value":0.04324,"currency":"USD"},{"executeDate":"2021-12-20","recordDate":"2021-12-21","paymentDate":"2021-12-31","value":0.10511,"currency":"USD"},{"executeDate":"2022-03-21","recordDate":"2022-03-22","paymentDate":"2022-03-31","value":0.03778,"currency":"USD"},{"executeDate":"2022-06-21","recordDate":"2022-06-22","paymentDate":"2022-06-30","value":0.04264,"currency":"USD"},{"executeDate":"2022-09-19","recordDate":"2022-09-20","paymentDate":"2022-09-23","value":0.03769,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBBQ\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBBQ\",pageSize:20,pageCount:6,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1110569578","title":"Keymed Bio-B Jumps Over 9% in Afternoon Trading, Company Holds Strong Competitive Edge Across Multiple Innovative Drug Areas Including Autoimmune and Oncology","url":"https://stock-news.laohu8.com/highlight/detail?id=1110569578","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110569578?lang=en_us&edition=fundamental","pubTime":"2026-09-29 13:50","pubTimestamp":1790661039,"startTime":"0","endTime":"0","summary":"Keymed Bio-B (02162) rose more than 8% in afternoon trading, climbing 8.95% as of press time to HKD 79.70, with a turnover of HKD 237 million.Earlier this month, Keymed Bio-B (02162) announced that...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNGR","IBBQ","BK1587","BK1583","MEDX","02162","06978","BK1161","BK1574","159992"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146102396","title":"CARSGEN-B (02171) Completes First Patient Infusion in China Phase I Registration Trial of CT1190B","url":"https://stock-news.laohu8.com/highlight/detail?id=1146102396","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146102396?lang=en_us&edition=fundamental","pubTime":"2026-09-29 08:10","pubTimestamp":1790640613,"startTime":"0","endTime":"0","summary":"According to an announcement by CARSGEN-B (02171), CT1190B, a universal CAR-T cell product targeting CD19/CD20, has completed the first patient infusion in its Phase I registration clinical trial...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02171","BK1574","BK1161","BMED","MDTX","IBBQ","IBBJ","BK1587","BK1585","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671257160","title":"Teva Wins US FDA Approval for Xgeva Biosimilar Degevma","url":"https://stock-news.laohu8.com/highlight/detail?id=2671257160","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671257160?lang=en_us&edition=fundamental","pubTime":"2026-09-29 04:00","pubTimestamp":1790625646,"startTime":"0","endTime":"0","summary":"Teva wins US FDA approval for Xgeva biosimilar DEGEVMATeva won FDA clearance for DEGEVMA (denosumab-adet), a biosimilar to Amgen’s Xgeva.Label covers Xgeva’s full uses, including prevention of bone co","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL4w4Bbr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3F31.USD","BK4588","IE0002141913.USD","BK4566","LU2112291526.USD","NDAQ","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","BCDF","LU2468319806.SGD","SG9999014039.USD","IBB","IE00BJT1NW94.SGD","IE00BQXX3D17.EUR","BK4112","LU2242646821.SGD","LU0889565916.HKD","LU1571399168.USD","LU0320765992.SGD","LU1061106388.HKD","LU2089984988.USD","TBXU","BK4585","BK4599","IBBQ","IE00B64PRP62.GBP","LU0122379950.USD","IE00B4R5TH58.HKD","SG9999014021.USD","AMGN","PBE","LU2242652126.USD","PJP","LU0289739699.SGD","IE00BN0W2V16.EUR","BBH","LU0314104364.USD","LU1057294990.SGD","IE00BKPKM429.USD","LU1983299246.USD","SG9999001440.SGD","BK4534","BK4139","BIB","IE00BN0W2W23.USD","IE00BFTCPJ56.SGD","LU0058720904.USD","BK4533","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671252933","title":"Ocular Therapeutix Tumbles on Rival Kodiak's Trial Win, Analyst Calls Selloff Overdone","url":"https://stock-news.laohu8.com/highlight/detail?id=2671252933","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671252933?lang=en_us&edition=fundamental","pubTime":"2026-09-29 02:37","pubTimestamp":1790620623,"startTime":"0","endTime":"0","summary":"BUZZ-Ocular Therapeutix tumbles on rival Kodiak's trial win, analyst calls selloff overdone** Shares of Ocular TherapeutixOCUL.Ofall 18.8% to $7.84 in afternoon trading** Kodiak Sciences'KOD.Oexperime","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K1CH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TBXU","LU2468319806.SGD","LU2023250504.SGD","BK4007","REGN","LU0053666078.USD","LU0889565916.HKD","LU0114720955.EUR","LU1917777945.USD","LU1974910355.USD","BK4588","LU2362541513.USD","IBBQ","LU2237438978.USD","LU0823434583.USD","LU2362540622.SGD","LU0320765992.SGD","LU0058720904.USD","OCUL","BK4139","LU2362541273.HKD","BK4505","LU0109394709.USD","BBH","LU0882574055.USD","LU0823416689.USD","KOD","LU0823434740.USD","LU2106854487.HKD","LU0289739699.SGD","BK4585","IBB","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671259773","title":"Analysts Offer Insights on Healthcare Companies: Regeneron (REGN) and Kodiak Sciences (KOD)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671259773","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671259773?lang=en_us&edition=fundamental","pubTime":"2026-09-29 00:00","pubTimestamp":1790611227,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Regeneron (REGN) and Kodiak Sciences (KOD). Regeneron (REGN) Citi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-regeneron-regn-and-kodiak-sciences-kod-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","KOD","LU0029874061.USD","LU0889565916.HKD","BK4585","XBI","LU0114720955.EUR","LU1974910355.USD","BK4581","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","BK4137","IBB","LU0053666078.USD","LU0823434740.USD","XLV","IBBQ","LABU","BK4505","BK4588","LU0128526141.USD","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","HCSG","LU0109394709.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670564812","title":"Mirum's Liver Infection Drug Lowers Virus Levels in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2670564812","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670564812?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:23","pubTimestamp":1790609027,"startTime":"0","endTime":"0","summary":"UPDATE 1-Mirum's liver infection drug lowers virus levels in late-stage studySept 28 (Reuters)-Mirum PharmaceuticalsMIRM.Oon Monday said its experimental hepatitis drug reduced levels of the virus in ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K14L:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","LU0122379950.USD","BIB","SG9999015952.SGD","LU0320765992.SGD","LU0859254822.USD","TMED","LU2468319806.SGD","LU1023059063.AUD","IE00B19Z3581.USD","BBH","LU1585245621.USD","LU2089984988.USD","LU0289739699.SGD","LU1057294990.SGD","BK4566","MEDI","LU2324357040.USD","LU1430594728.SGD","LU0965509101.SGD","IE00B3T34201.USD","LU0882574055.USD","LU1934455863.HKD","LU2357627491.SGD","LU0861579265.USD","SG9999015986.USD","LU1839511570.USD","MIRM","GILD","IE00BKVL7J92.USD","LU1066053197.SGD","BK4585","LU0234570918.USD","LU1066051498.USD","IBB","BMED","LU2087621335.USD","IE00BSNM7G36.USD","BK4139","LU0889565916.HKD","TBXU","LU2112291526.USD","LU0965509283.SGD","BK4588","LU0058720904.USD","LU1778281490.HKD","LU1934455194.USD","IBBQ","IE0002270589.USD","LU1674673428.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670620256","title":"Inside the Eye-Drug Breakthrough That Sent Kodiak Sciences up 156%","url":"https://stock-news.laohu8.com/highlight/detail?id=2670620256","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670620256?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:11","pubTimestamp":1790608260,"startTime":"0","endTime":"0","summary":"Shares of Kodiak Sciences more than doubled Monday after two experimental eye drugs succeeded in a late-stage trial, positioning the biopharmaceutical company to get its first product to market.Kodiak","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2362541513.USD","LU2089984988.USD","BK4505","KOD","BK4588","BBH","LU0823416689.USD","TBXU","LU2023250504.SGD","LU0109394709.USD","LU1974910355.USD","LU2362541273.HKD","BK4585","LU0823434583.USD","LU2468319806.SGD","LU2362540622.SGD","BK4139","IBB","LU0889565916.HKD","LU0823434740.USD","IBBQ","LU0289739699.SGD","LU2237438978.USD","OTLK","LU0320765992.SGD","LU0882574055.USD","LU0058720904.USD","LU0114720955.EUR","LU2106854487.HKD","REGN","LU0053666078.USD","LU1917777945.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670256598","title":"Amgen Stock Forecast: Sjögren’s Trial Success Tests AMGN’s Pipeline Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2670256598","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670256598?lang=en_us&edition=fundamental","pubTime":"2026-09-28 23:00","pubTimestamp":1790607600,"startTime":"0","endTime":"0","summary":"TradingKey - Amgen’s latest Sjögren’s trial success adds to its pipeline, while Repatha growth and MariTide trials shape the AMGN stock outlook for 2026.","market":"sh","thumbnail":"https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/uploads/20260928/AMGEN-b0736da492b74294b066d7d43a826369.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/analysis/stocks/us-stocks/262189733-stocks-amgen-stock-forecast-sjogrens-trial-maritide-2026-tradingkey","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AZN","LU2237443622.USD","PBE","LU2089984988.USD","LU0122379950.USD","LU1829250122.USD","IE00B4R5TH58.HKD","LU0320765992.SGD","BIB","LU2237443382.USD","LU2468319806.SGD","BK4534","IBB","BK4588","LU0058720904.USD","IE0002141913.USD","LU0289739699.SGD","LU1571399168.USD","LU2237443465.HKD","LU2237443549.SGD","BK4566","IE00BFTCPJ56.SGD","LU1057294990.SGD","BBH","PJP","AZNH","BK4581","IE00BJJMRZ35.SGD","LU0029864427.USD","IE0009355771.USD","LU2112291526.USD","LU0432979614.USD","LU2237443895.HKD","LU0109394709.USD","AMGN","LU0889565916.HKD","LU2236285917.USD","BK4533","LU2456880835.USD","TBXU","IE00B3T34201.USD","LU2237443978.SGD","SG9999001440.SGD","LU0708994859.HKD","LU2242652126.USD","IBBQ","BK4007","IE00BJT1NW94.SGD","LU0128525929.USD","LU0310800379.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670255552","title":"US Drugmakers Turn to China for Licensing Deals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670255552","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670255552?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:31","pubTimestamp":1790605880,"startTime":"0","endTime":"0","summary":"FACTBOX-US drugmakers turn to China for licensing dealsSept 28 (Reuters)-MerckMRK.Non Monday agreed to payChinese biotechSciBrunch Therapeutics $400 million upfront for global rights to an experimenta","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0UD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0162691827.USD","LU1868837136.USD","IE000M9KFDE8.USD","LU0316494557.USD","LU1868836757.USD","XLV","LU0053666078.USD","LU2347655073.USD","LU1941712348.USD","IE00BWXC8680.SGD","LU0058720904.USD","LU2028103732.USD","LU1732799900.SGD","LU2361044865.SGD","LU1261432733.SGD","LU2471134523.USD","LU0203201768.USD","LU0265550359.USD","IE00BVYPNV92.GBP","BK4568","LU1069347547.HKD","LU2433249047.HKD","LU0323591593.USD","LU1929549753.HKD","BMY","LU2357627491.SGD","MEDI","LU0109394709.USD","LU1988902786.USD","LU2237438978.USD","IE00BBT3K403.USD","KURE","IE00B19Z3581.USD","LLYX","LU0306807586.USD","LU2089283258.USD","FHLC","LU0912757837.SGD","LU2125154778.USD","LU2756315318.SGD","LU0607220059.USD","MHIP","LU1066051225.USD","LU0106261372.USD","IE00BJJMRZ35.SGD","LU0310800379.SGD","LU0708995401.HKD","LU1989772840.SGD","LU0061475181.USD","LU1934455863.HKD","THNR","LU1670711123.USD","LU2362541513.USD","LU0244354667.USD","PFE","LU2236285917.USD","LU2417539215.USD","LU1670710588.SGD","LU0320765059.SGD","SGXZ81514606.USD","SG9999015945.SGD","LU1699723380.USD","SGXZ99366536.SGD","LU0417517546.SGD","LU0455707207.USD","LU1989772923.USD","LU0265550946.USD","LU0708994859.HKD","LU1064131342.USD","IE000BZT7R73.USD","LU0158827948.USD","LU0267386448.USD","LU0109391861.USD","LU2324357040.USD","PJP","LU0079474960.USD","LU1883839398.USD","LU2097828474.EUR","LU0471298694.HKD","LU0823416689.USD","IE00B3T34201.USD","LU2456880835.USD","LU1917777945.USD","IE00B4JS1V06.HKD","LU0942090050.USD","LU2213496289.HKD","LU0321505868.SGD","LU0320765646.SGD","LU2361045086.USD","LU2112291526.USD","GDOC","LU0326950275.SGD","LU0256863811.USD","LU2108987350.USD","SG9999002224.SGD","ELIS","LU0210536198.USD","LU1066053197.SGD","ELIL","LU0861579265.USD","LU1548497426.USD","LU2168564222.USD","LU1116320901.HKD","LU0122379950.USD","LU0502904849.HKD","IE0002270589.USD","SG9999002232.USD","LU0158827781.USD","IE00BFTCPJ56.SGD","REGN","LU0823434740.USD","LU1934455194.USD","SGXZ31699556.SGD","SG9999001440.SGD","LU0726765562.USD","LU2362540622.SGD","LU2552382132.HKD","LU1093756168.USD","SG9999003800.SGD","IHE","LU0170899867.USD","LU1732800096.USD","SG9999013999.USD","LLYZ","LU0345770993.USD","CURE","LU0070302665.USD","LU2097828805.USD","LU1934455277.USD","LU1868836914.USD","LU1691799644.USD","LLY","LU1366192091.USD","LU0130517989.USD","SG9999015978.USD","IE00B4R5TH58.HKD","SG9999014542.SGD","LU0096364046.USD","LU0203347892.USD","LU0432979614.USD","MRK","LU0859254822.USD","LU1035775433.USD","LU1236620834.HKD","LU0057025933.USD","LU0211331839.USD","LU0795875169.SGD","LU0882574139.USD","BK4532","LU1032466523.USD","IE00BKDWB100.SGD","LU2168563687.JPY","LU1037948541.HKD","LU2360032135.SGD","LU1551013425.SGD","LU2746668461.USD","IE000WAW04H5.SGD","SG9999015986.USD","LU0964807845.USD","LU0069063385.USD","LU1035773651.USD","LU0310799852.SGD","TRUH","LU0466842654.USD","LU2168564495.EUR","IE00BK4W5L77.USD","LU1003077747.HKD","LU0965509101.SGD","LU2462157665.USD","LU0203345920.USD","LU2125154935.USD","SG9999015341.SGD","AGNG","IE00BJJMRX11.SGD","LU2211815571.USD","IE0001KFT4U8.USD","LU0203202063.USD","IE0005OL40V9.USD","SG9999014898.SGD","LU0965508806.USD","LU2125909593.SGD","LU0225284248.USD","LU1941712264.USD","LU2491050154.USD","LU1280957306.USD","LU1983299246.USD","IE00B3PB1722.GBP","LU2746668974.SGD","IE00BVYPNW00.USD","LU2237443549.SGD","LU2491049909.HKD","IBB","LU0463099449.HKD","LU0198837287.USD","01801","LU2023250504.SGD","IE00BGHQF631.EUR","PAWZ","LU1894683348.USD","LU0097036916.USD","LU2129689605.HKD","LU2237443895.HKD","LU0820561818.USD","BK4581","LU0820562030.AUD","LU2111349929.HKD","LU1267930573.SGD","SG9999018865.SGD","IE00BJT1NW94.SGD","IE000MB6IJN5.SGD","LU2552382215.SGD","LU1244550221.USD","BK4533","IBBQ","IE00BN29S564.USD","LU0661504455.SGD","IE00BLSP4239.USD","LU2602419157.SGD","LU2242644610.SGD","LU0545039389.USD","LU0133085943.USD","LU0320765489.SGD","LU0683600562.USD","LU1037948897.HKD","LU1093756325.SGD","LU2125909247.SGD","LU0237698245.USD","LU0689472784.USD","LU0980610538.SGD","LU2237443382.USD","VHT","LU0114720955.EUR","IE0000B7K699.USD","WDNA","LU0289739343.SGD","SG9999014914.USD","LU2750360641.GBP","IE00B19Z3B42.SGD","RXL","LU2097828557.USD","IE00B1XK9C88.USD","LU1244550494.USD","LU0094547139.USD","LU1066051498.USD","LU1868837300.USD","SGXZ57979304.SGD","LU1868836591.USD","LU0006306889.USD","LU2242646821.SGD","LU2237443465.HKD","IE00B775H168.HKD","LU2750360997.AUD","IE00BFXG1179.USD","LU0238689110.USD","IE00BSNM7G36.USD","LU0648001328.SGD","BK4588","LU2461242641.AUD","LU0289739699.SGD","LU0738911758.USD","LU0965509010.AUD","IXJ","BK4592","IE0004445239.USD","LU1201861249.SGD","LU0306806265.USD","LU2168564065.EUR","GB00BDT5M118.USD","LU1074936037.SGD","BK1161","IE000F7OJYX1.SGD","LU1670628061.USD","LU0321505439.SGD","LU0130102774.USD","LU2097828714.EUR","LU0029864427.USD","LU0234570918.USD","LU2023250843.SGD","LU1831875114.USD","LU0456855351.SGD","LU2089984988.USD","LU2106854487.HKD","LU2063271972.USD","LU2471134879.HKD","LU0477156953.USD","LU2328871848.SGD","SG9999011175.SGD","LU2552382058.USD","LU0471298777.SGD","IE0004445015.USD","LU1670627923.USD","LU1670710661.SGD","LU0868494617.USD","LU2087621335.USD","LU1923622614.USD","LU1804176565.USD","LU1267930730.SGD","LU0289961442.SGD","LU0823434583.USD","LU2264538146.SGD","BK4550","IE00B42XCP33.USD","LU0353189680.USD","LU1712237335.SGD","LU2596442595.SGD","GLAM","LU1069344957.HKD","LU0320765992.SGD","LU1236620750.USD","LU0965509283.SGD","LU2271345857.HKD","HRTS","LU0354030511.USD","IE0009355771.USD","LU1291159041.SGD","LU0795875086.SGD","SG9999014567.USD","MEDX","IE00BLSP4452.SGD","LU1670711040.USD","LU0640476718.USD","LU2468319806.SGD","LU1496350502.SGD","IE00BK4W5M84.HKD","IE00BFSS7M15.SGD","SG9999001176.SGD","LU2097828631.EUR","LLII","LU2360106947.USD","BK4139","LU0949170772.SGD","LU1894683264.USD","LU2129689431.USD","SG9999017495.SGD","LU0072461881.USD","IE00B2B36J28.USD","LU1720051108.HKD","LU2237443978.SGD","SGXZ51526630.SGD","LU1839511570.USD","HK0000165453.HKD","LU0511384066.AUD","SG9999018857.SGD","SG9999014559.SGD","SG9999014880.SGD","LU0234572021.USD","SG9999015952.SGD","BK4559","PPH","LU1232071149.USD","IE00BJJMRY28.SGD","LU1323610961.USD","LU1066051811.HKD","LU0985481810.HKD","LU2471134952.CNY","LU0124676726.USD","LU1814569148.SGD","SG9999014906.USD","TMED","LU1979441026.SGD","LU0211328371.USD","LU1496350171.SGD","IE00BN8TJ469.HKD","LU2237443622.USD","LU1061106388.HKD","LU0266013472.USD","LU1551013342.USD","BMED","LU1629891620.HKD","LU1127390331.HKD","LU1162221912.USD","IYH","LU0174119429.USD","LU0553294199.USD","LU0345770308.USD","LU2168564149.EUR","LU2488822045.USD","LU2347655156.SGD","LU0256863902.USD","SG9999001176.USD","LU2462591350.SGD","LU1571399168.USD","ILDR","LU0943347566.SGD","LU0149534421.HKD","BK4599","LU2089284900.SGD","LU1057294990.SGD","LU0882574055.USD","LU2896262040.SGD","LU2087625088.SGD","LU1969619763.USD","LU0985320562.USD","TBXU","BK1583","LU2242652126.USD","BK4585","LU1430594728.SGD","IE00BKPKM429.USD","LU1585245621.USD","LU0208291251.USD","SG9999014575.USD","LU2361044949.HKD","LU1023059063.AUD","IE00BFSS8Q28.SGD","IE00BJLML261.HKD","ABBV","LU0889565916.HKD","BK4534","BBH","BK1589","LU1116320737.USD","LU2491050071.SGD","LU0098860793.USD","LU1188198961.HKD","LU0385154629.USD","LU2023251221.USD","LU1244550577.SGD","IE00B1BXHZ80.USD","LU1974910355.USD","LU2265009873.SGD","LU0395794307.EUR","LU2756315664.SGD","LU2129689514.USD","LU2357305700.SGD","LU0689626769.HKD","LU2471134796.USD","LU1145028129.USD","LU1989771016.USD","LU0225283273.USD","LU0472753341.HKD","IE000SO60NU8.SGD","LU0128525929.USD","IE00B7KXQ091.USD","LU0868494708.USD","SG9999015358.SGD","LU1718418525.SGD","LU0672654240.SGD","BK4516","LU2023250330.USD","LU2362541273.HKD","LU1623119135.USD","BK4566","LU0787776722.HKD","LU0786609619.USD","CANC","LU0211327993.USD","BK4007","IE00BDGV0183.EUR","IE0002141913.USD","LU0225771236.USD","LU2133065610.SGD","LU1267930490.SGD","LU1720051017.SGD","LU0354030438.USD","JDOC","LU0820561909.HKD","OZEM","FTXH","LU0353189763.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1134119945","title":"Mabwell's Subsidiary Lianwei Chuangyuan to Bring In Investors, Aiming to Boost Innovative Drug Business","url":"https://stock-news.laohu8.com/highlight/detail?id=1134119945","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1134119945?lang=en_us&edition=fundamental","pubTime":"2026-09-28 22:08","pubTimestamp":1790604493,"startTime":"0","endTime":"0","summary":"Mabwell (Shanghai) Bioscience Co., Ltd. (688062.SH) has announced that, in line with its strategic development plan and to further advance its innovative drug business while focusing on technological...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","159992","BK1574","MEDX","LNGR","BK1161","IBBQ","688062","06978","02493"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191494287","title":"Changchun High-Tech's GenSci136 Injection Receives Approval for Domestic Clinical Trial Application","url":"https://stock-news.laohu8.com/highlight/detail?id=1191494287","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191494287?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:36","pubTimestamp":1790595380,"startTime":"0","endTime":"0","summary":"Changchun High-Tech Industry (Group) Co.,Ltd. (000661.SZ) has announced that its subsidiary, Changchun GeneScience Pharmaceutical Co., Ltd. (\"GeneScience Pharmaceutical\"), has received a Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["000661","BK0057","IBBJ","IBBQ","BK0028","BK0188","BK0239","BMED","BK0046","BK0075","PSYK","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670019231","title":"Xilio Therapeutics Names Yariv Houvras Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2670019231","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670019231?lang=en_us&edition=fundamental","pubTime":"2026-09-28 19:30","pubTimestamp":1790595055,"startTime":"0","endTime":"0","summary":"Xilio Therapeutics names Yariv Houvras chief medical officerXilio Therapeutics named Yariv J. Houvras chief medical officer on Sept. 28, 2026.He previously led clinical and translational development a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nNDL8GCH5H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKVL7J92.USD","BCDF","BIB","IBB","LU0823416689.USD","BBH","IE00B3QW5Z07.USD","IE00BKPKM429.USD","SG9999014021.USD","BK4532","LU1571399168.USD","LU1934455277.USD","LU0859254822.USD","LU2210149790.SGD","LU2089984988.USD","BMED","LU1066051498.USD","XLO","SG9999014013.SGD","LU0965509101.SGD","GILD","LU1430594728.SGD","LU1066053197.SGD","LU2468319806.SGD","LU0965509283.SGD","TBXU","IE00BN0W2V16.EUR","BK4566","NDAQ","TMED","LU0861579265.USD","BK4583","IE00B19Z3B42.SGD","LU0234570918.USD","LU1934455863.HKD","IBBQ","IE00B3T34201.USD","LU2087621335.USD","SG9999015952.SGD","LU1037948897.HKD","LU2112291526.USD","MEDI","LU2210150020.SGD","BK4568","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","LU1061106388.HKD","LU1839511570.USD","IE00B19Z3581.USD","SG9999015978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670239992","title":"Kodiak Sciences Rises After Eye-Disease Drugs Meet Trial Goals","url":"https://stock-news.laohu8.com/highlight/detail?id=2670239992","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670239992?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:50","pubTimestamp":1790592624,"startTime":"0","endTime":"0","summary":"BUZZ-Kodiak Sciences rises after eye-disease drugs meet trial goals** Shares of drug developer Kodiak SciencesKOD.Orise 43.9% to $46.56 premarket** Co says its experimental drugs Zenkuda and tabirafusp-ted met the main goals of a late-stage trial in patients with wet age-related macular degeneration** Both drugs achieved vision gains at one year that were not inferior to aflibercept, the comparison treatment** Wet age-related macular degeneration causes abnormal blood vessels to leak beneath the retina and can lead to loss of central vision** About 54% of Zenkuda patients reached a six-month dosing interval, potentially reducing the number of eye injections needed** Both drugs showed safety broadly consistent with aflibercept; Kodiak plans further analyses to identify which patients may benefit most from tabirafusp-ted** Co plans to seek US approval for Zenkuda in Q4 2026, using results from five successful late-stage studies across three retinal diseases** KOD up 15.7% YTD, as of last","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260928:nL4N45K0P4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BBH","LU0320765992.SGD","LU2106854487.HKD","LU2362540622.SGD","KOD","LU0889565916.HKD","BK4585","LU0114720955.EUR","LU1974910355.USD","LU2362541513.USD","REGN","LU2023250504.SGD","LU0058720904.USD","LU0823416689.USD","LU2362541273.HKD","IBB","LU0053666078.USD","LU0109394709.USD","IBBQ","BK4505","BK4588","LU0289739699.SGD","LU0882574055.USD","LU2089984988.USD","LU0823434583.USD","LU2468319806.SGD","TBXU","LU0823434740.USD","LU1917777945.USD","LU2237438978.USD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109891748","title":"Sun-Novo Pharmaceutical's STC008 Injection Meets Expected Goals in Phase I Trial for Cancer Cachexia in Advanced Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1109891748","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109891748?lang=en_us&edition=fundamental","pubTime":"2026-09-28 18:08","pubTimestamp":1790590125,"startTime":"0","endTime":"0","summary":"Beijing Sun-Novo Pharmaceutical Research Co.,Ltd. (688621.SH) has announced that its wholly-owned subsidiary, Chengdu Novo-St Biotechnology Co., Ltd. (\"Novo-St\"), has achieved the expected objectives...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688621","BK0216","PSYK","BMED","IBBJ","IBBQ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136095749","title":"Betta Pharmaceuticals (300558.SZ): BPI-572270 Capsules Approved for Clinical Trials in Australia","url":"https://stock-news.laohu8.com/highlight/detail?id=1136095749","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136095749?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:32","pubTimestamp":1790587955,"startTime":"0","endTime":"0","summary":"Betta Pharmaceuticals Co.,Ltd. (300558.SZ) has announced that its wholly-owned subsidiary, Hangzhou Jingyao Biotechnology Co., Ltd. (\"Jingyao Biotech\"), has received approval from Australia's Human...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","IBBJ","BK0239","PSYK","MDTX","BK0060","300558","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119593670","title":"Wuhan Hiteck Biological Pharma Secures Clinical Trial Approval for Epranemide Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1119593670","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119593670?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:26","pubTimestamp":1790587580,"startTime":"0","endTime":"0","summary":"Wuhan Hiteck Biological Pharma Co.,Ltd. (300683.SZ) has announced that the company recently received a Drug Clinical Trial Approval Notice issued by the National Medical Products Administration.The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSYK","BMED","300683","IBBJ","IBBQ","MDTX","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112995199","title":"Dezhan Healthcare's Subsidiary Receives FDA Approval for Clinical Trial of Innovative Drug WYY026B Injection","url":"https://stock-news.laohu8.com/highlight/detail?id=1112995199","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112995199?lang=en_us&edition=fundamental","pubTime":"2026-09-28 17:10","pubTimestamp":1790586629,"startTime":"0","endTime":"0","summary":"Dezhan Healthcare Company Limited (000813.SZ) has announced that its wholly-owned subsidiary, Beijing Honghui Xin Pharmaceutical Technology Co., Ltd., recently received notification from the U.S....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","BK0114","IBBQ","IBBJ","BMED","BK1574","LNGR","159992","BK4585","06978","MEDX","PSYK","BK0239","BK0060","MDTX","000813","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670808280","title":"Sino Biopharmaceutical Stock Slides 1.3% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2670808280","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670808280?lang=en_us&edition=fundamental","pubTime":"2026-09-28 16:33","pubTimestamp":1790584380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. shed 1.3% to 5.50 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.5% to 24642.51.This was the stock's fifth consecutive day of losses.Sino Biopharmaceutical Ltd. closed 36% short of its 52-week high of HK$8.54, which the company reached Oct. 8.The stock underperformed when compared to some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 0.6% and Amgen Inc. remained unchanged.Trading volume totaled 57.5 million shares, compared to the 50-day average of 82.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","LU0868494617.USD","TBXU","LU0889565916.HKD","IE0002141913.USD","PBE","BK1515","IE00BJT1NW94.SGD","BK4533","LU0320765992.SGD","BK4599","BBH","01177","SG9999001440.SGD","LU0109394709.USD","LU1983299246.USD","IE00B2B36J28.USD","LU2242646821.SGD","AMGN","LU1057294990.SGD","LU0058720904.USD","BK4581","91335","IBB","BK1521","BK4534","BK4585","BK1191","LU2089984988.USD","LU2468319806.SGD","BIB","BK1589","IE00BJJMRZ35.SGD","BK4588","PJP","IE00BZ08YS42.EUR","LU0289739699.SGD","IE00BFTCPJ56.SGD","IE00BZ08YT58.USD","LU1571399168.USD","BK4139","IE00B4R5TH58.HKD","LU0122379950.USD","LU2242652126.USD","LU1061106388.HKD","LU2112291526.USD","IE0009355771.USD","IE00BZ08YR35.GBP","LU1023059063.AUD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197962641","title":"Sichuan Biokin Pharmaceutical Receives Clinical Trial Approval for Injectable BL-M12D1 (ADC)","url":"https://stock-news.laohu8.com/highlight/detail?id=1197962641","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197962641?lang=en_us&edition=fundamental","pubTime":"2026-09-27 19:26","pubTimestamp":1790508369,"startTime":"0","endTime":"0","summary":"Sichuan Biokin Pharmaceutical Co.,Ltd. (688506.SH) has announced that the company recently received the official Drug Clinical Trial Approval Notice issued by the National Medical Products...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["91194","688506","MDTX","IBBJ","ADC","IBBQ","BMED","BK0239","BK4080","NETL","BK4231","PSYK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670471175","title":"Regeneron (REGN) Receives a Hold from Bernstein","url":"https://stock-news.laohu8.com/highlight/detail?id=2670471175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670471175?lang=en_us&edition=fundamental","pubTime":"2026-09-26 20:55","pubTimestamp":1790427321,"startTime":"0","endTime":"0","summary":"Bernstein analyst Eve Burstein maintained a Hold rating on Regeneron yesterday and set a price target of $756.00. The company’s shares closed yeste...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/regeneron-regn-receives-a-hold-from-bernstein-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IBB","LU2023250504.SGD","LU0889565916.HKD","LU2468319806.SGD","BK4139","LU0058720904.USD","LU0823434583.USD","REGN","LU0882574055.USD","BBH","LU0289739699.SGD","LU1917777945.USD","LU0823434740.USD","LU2237438978.USD","TBXU","LU2362540622.SGD","LU0823416689.USD","BK4588","LU0053666078.USD","LU0109394709.USD","BK4585","LU2106854487.HKD","LU0114720955.EUR","LU2362541513.USD","LU2089984988.USD","LU2362541273.HKD","LU0320765992.SGD","LU1974910355.USD","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":6,"totalSize":200,"code":"91000000","status":"200"}]}}